Showing results (451-460 of 1,658) with videos related to

Sort By:
Pageof 166
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 23, 2013
Sclerostin: another bone-related protein related to all-cause mortality in haemodialysis?Liesbeth Viaene, Geert J Behets, Kathleen Claes, et al.
Hepatology (Baltimore, Md.)|March 8, 2013
An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: implications for hemostasis and clinical outcomeGreg C G Hugenholtz, Jelle Adelmeijer, Joost C M Meijers, et al.
Journal of Pediatric Surgery|June 1, 1989
A model for aganglionosis in the chicken embryoJ H Meijers, D Tibboel, A W van der Kamp, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 22, 2020
Apixaban in patients on haemodialysis: a single-dose pharmacokinetics studyInes Van den Bosch, Thomas Bouillon, Peter Verhamme, et al.
American Journal of Nephrology|July 28, 2011
Reduction in protein-bound solutes unacceptable as marker of dialysis efficacy during alternate-night nocturnal hemodialysisBjorn Meijers, Nigel D Toussaint, Timothy Meyer, et al.
The Journal of Climate Change and Health|February 6, 2026
Understanding environmental decision making: The association between stages of decision making and decisional conflictLetizia Richelli, Eline L F M G Vissers, Alessandra Gorini, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 11, 2013
Reasons for dose reduction of mycophenolate mofetil during the first year after renal transplantation and its impact on graft outcomeThomas Vanhove, Dirk Kuypers, Kathleen J Claes, et al.
Lancet (London, England)|March 19, 2002
Bioavailability of subcutaneous low-molecular-weight heparin to patients on vasopressorsJanine Dörffler-Melly, Evert de Jonge, Anne-Corneliede Pont, et al.
Pageof 166